228 related articles for article (PubMed ID: 32528464)
21. Environmental Enteric Dysfunction is Associated with Carnitine Deficiency and Altered Fatty Acid Oxidation.
Semba RD; Trehan I; Li X; Moaddel R; Ordiz MI; Maleta KM; Kraemer K; Shardell M; Ferrucci L; Manary M
EBioMedicine; 2017 Mar; 17():57-66. PubMed ID: 28122695
[TBL] [Abstract][Full Text] [Related]
22. Immune cell dysregulation as a mediator of fibrosis in systemic sclerosis.
Fang D; Chen B; Lescoat A; Khanna D; Mu R
Nat Rev Rheumatol; 2022 Dec; 18(12):683-693. PubMed ID: 36352098
[TBL] [Abstract][Full Text] [Related]
23. Serum metabolite differences detected by HILIC UHPLC-Q-TOF MS in systemic sclerosis.
Sun C; Zhu H; Wang Y; Han Y; Zhang D; Cao X; Alip M; Nie M; Xu X; Lv L; Feng X; Sun L; Wang D
Clin Rheumatol; 2023 Jan; 42(1):125-134. PubMed ID: 36127550
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes.
Farina A; Peruzzi G; Lacconi V; Lenna S; Quarta S; Rosato E; Vestri AR; York M; Dreyfus DH; Faggioni A; Morrone S; Trojanowska M; Farina GA
Arthritis Res Ther; 2017 Feb; 19(1):39. PubMed ID: 28245863
[TBL] [Abstract][Full Text] [Related]
25. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
[TBL] [Abstract][Full Text] [Related]
26. Immunological basis of systemic sclerosis.
Zuber JP; Spertini F
Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii23-5. PubMed ID: 16987826
[TBL] [Abstract][Full Text] [Related]
27. Anti-CXCL4 Antibody Reactivity Is Present in Systemic Sclerosis (SSc) and Correlates with the SSc Type I Interferon Signature.
Lande R; Mennella A; Palazzo R; Pietraforte I; Stefanantoni K; Iannace N; Butera A; Boirivant M; Pica R; Conrad C; Chizzolini C; Riccieri V; Frasca L
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707718
[TBL] [Abstract][Full Text] [Related]
28. Role of Alarmins in the Pathogenesis of Systemic Sclerosis.
Giovannetti A; Straface E; Rosato E; Casciaro M; Pioggia G; Gangemi S
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679721
[TBL] [Abstract][Full Text] [Related]
29. Serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis.
Joseloff E; Sha W; Bell SC; Wetmore DR; Lawton KA; Milburn MV; Ryals JA; Guo L; Muhlebach MS
Pediatr Pulmonol; 2014 May; 49(5):463-72. PubMed ID: 23847148
[TBL] [Abstract][Full Text] [Related]
30. Expression of NLRP3 inflammasome, cytokines and vascular mediators in the skin of systemic sclerosis patients.
Martínez-Godínez MA; Cruz-Domínguez MP; Jara LJ; Domínguez-López A; Jarillo-Luna RA; Vera-Lastra O; Montes-Cortes DH; Campos-Rodríguez R; López-Sánchez DM; Mejía-Barradas CM; Castelán-Chávez EE; Miliar-García A
Isr Med Assoc J; 2015 Jan; 17(1):5-10. PubMed ID: 25739168
[TBL] [Abstract][Full Text] [Related]
31. Low heme oxygenase-1 levels in patients with systemic sclerosis are associated with an altered Toll-like receptor response: another role for CXCL4?
van Bon L; Cossu M; Scharstuhl A; Pennings BW; Vonk MC; Vreman HJ; Lafyatis RL; van den Berg W; Wagener FA; Radstake TR
Rheumatology (Oxford); 2016 Nov; 55(11):2066-2073. PubMed ID: 27411481
[TBL] [Abstract][Full Text] [Related]
32. The immunopathogenesis of fibrosis in systemic sclerosis.
Brown M; O'Reilly S
Clin Exp Immunol; 2019 Mar; 195(3):310-321. PubMed ID: 30430560
[TBL] [Abstract][Full Text] [Related]
33. T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.
Almeida I; Silva SV; Fonseca AR; Silva I; Vasconcelos C; Lima M
Clin Rev Allergy Immunol; 2015 Dec; 49(3):347-69. PubMed ID: 26445774
[TBL] [Abstract][Full Text] [Related]
34. CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis.
Taniguchi T; Miyagawa T; Toyama S; Yamashita T; Nakamura K; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S; Asano Y
Exp Dermatol; 2018 Sep; 27(9):1030-1037. PubMed ID: 29947047
[TBL] [Abstract][Full Text] [Related]
35. Role of IL-13 in systemic sclerosis.
Fuschiotti P
Cytokine; 2011 Dec; 56(3):544-9. PubMed ID: 21920770
[TBL] [Abstract][Full Text] [Related]
36. Potential immunologic targets for treating fibrosis in systemic sclerosis: a review focused on leukocytes and cytokines.
Hasegawa M; Takehara K
Semin Arthritis Rheum; 2012 Dec; 42(3):281-96. PubMed ID: 22542279
[TBL] [Abstract][Full Text] [Related]
37. Imbalance between T helper 17 and regulatory T cell subsets plays a significant role in the pathogenesis of systemic sclerosis.
Mo C; Zeng Z; Deng Q; Ding Y; Xiao R
Biomed Pharmacother; 2018 Dec; 108():177-183. PubMed ID: 30219674
[TBL] [Abstract][Full Text] [Related]
38. Altered B lymphocyte homeostasis and functions in systemic sclerosis.
Forestier A; Guerrier T; Jouvray M; Giovannelli J; Lefèvre G; Sobanski V; Hauspie C; Hachulla E; Hatron PY; Zéphir H; Vermersch P; Labalette M; Launay D; Dubucquoi S
Autoimmun Rev; 2018 Mar; 17(3):244-255. PubMed ID: 29343447
[TBL] [Abstract][Full Text] [Related]
39. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
[TBL] [Abstract][Full Text] [Related]
40. Carnitine transport and fatty acid oxidation.
Longo N; Frigeni M; Pasquali M
Biochim Biophys Acta; 2016 Oct; 1863(10):2422-35. PubMed ID: 26828774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
